title: Reducing daptomycin expenditures by standardizing doses.
authors.affiliation: Department of PharmacyUniversity of Maryland Medical Center22 South Greene StreetBaltimore, MD 21201.
authors.forename: Dominick
authors.initials: D
authors.lastname: Memoli
authors.forename: Adrienne
authors.initials: A
authors.lastname: Shepardson
authors.forename: Manjari
authors.initials: M
authors.lastname: Joshi
authors.forename: Emily
authors.initials: E
authors.lastname: Heil
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000191:economics* / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000191:economics*; D017321:Clinical Trials, Phase I as Topic; D017576:Daptomycin / Q000008:administration & dosage / Q000191:economics* / Q000627:therapeutic use*; D006801:Humans; D012015:Reference Standards; D014640:Vancomycin / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin; D017576:Daptomycin